ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.898,80
0,00%
S&P 500
5.352,96
0,00%
US Dollar vs BRL
5,2926
0,65%
Bitcoin
71.102,06
0,48%
Brent Oil
79,655
-0,28%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Zynerba Pharmaceuticals Inc (ZYNE)

  7. Zynerba Pharmaceuticals Inc (ZYNE) Notícias

ZYNE

Zynerba Pharmaceuticals (ZYNE)

Zynerba Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ZYNE
DataHoraFonteTítuloCódigoCompanhia
08/02/202421:22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
19/10/202317:48Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
12/10/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202311:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202310:27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202310:27Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202309:56Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202309:31Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202309:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202309:00PR Newswire (US)HARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA PHARMACEUTICALS AND EXPANDS PIPELINENASDAQ:ZYNEZynerba Pharmaceuticals Inc
04/10/202317:05GlobeNewswire Inc.Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and InstructionsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
29/09/202310:00GlobeNewswire Inc.Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023NASDAQ:ZYNEZynerba Pharmaceuticals Inc
27/09/202309:00PR Newswire (US)HARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.NASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/09/202317:15GlobeNewswire Inc.Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q11.2 Deletion Syndrome at The Society for the Study of Behavioural Phenotypes (SSBP) 25th International Research SymposiumNASDAQ:ZYNEZynerba Pharmaceuticals Inc
05/09/202317:39Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
28/08/202310:05Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
28/08/202309:23Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:ZYNEZynerba Pharmaceuticals Inc
24/08/202318:23Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:ZYNEZynerba Pharmaceuticals Inc
15/08/202317:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/08/202318:29Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/08/202318:20Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/08/202308:36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/08/202308:30PR Newswire (US)HARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.NASDAQ:ZYNEZynerba Pharmaceuticals Inc
08/08/202317:13Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ZYNEZynerba Pharmaceuticals Inc
08/08/202317:05GlobeNewswire Inc.Zynerba Pharmaceuticals Announces New Date for Reconvened Annual MeetingNASDAQ:ZYNEZynerba Pharmaceuticals Inc
28/06/202317:21Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ZYNEZynerba Pharmaceuticals Inc
28/06/202317:05GlobeNewswire Inc.Zynerba Pharmaceuticals Announces Further Adjournment of Annual MeetingNASDAQ:ZYNEZynerba Pharmaceuticals Inc
21/06/202317:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ZYNEZynerba Pharmaceuticals Inc
20/06/202308:00GlobeNewswire Inc.Zynerba Pharmaceuticals to Present at the H.C. Wainwright 4th Annual Neuropsychiatry Virtual ConferenceNASDAQ:ZYNEZynerba Pharmaceuticals Inc
15/06/202317:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZYNEZynerba Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ZYNE

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
BRKM5
BRASKEM PNA
BOV
HBOR3
HELBOR ON
BOV
RPMG3
PET MANGUINH ON
BOV
COGN3
COGNA ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
TELB4
TELEBRAS PN
BOV
KRSA3
Kora Saude Participacoes... ON
BOV
PRIO3
PETRORIO ON
BOV
CMIG4
CEMIG PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados